Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842033 · ClinicalTrials.gov registry record · NA
Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients
A NA study of Pediatric Asthma, sponsored by Arkansas Children's Hospital Research Institute.
- Active
- Registry status
- NA
- Development phase
- 370
- Enrollment target
- 1
- Study location
NCT03842033: Active NA study of Pediatric Asthma, sponsored by Arkansas Children's Hospital Research Institute.
NCT03842033 is a NA study of Pediatric Asthma that is active but no longer recruiting, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 370 participants, below the 7,674-participant average among 9 other Pediatric Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03842033, a NA study of Pediatric Asthma, is active but no longer recruiting, sponsored by Arkansas Children's Hospital Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 370 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan.
Primary Outcome
The primary outcome measure will be the change from ACT score ≤19 (uncontrolled asthma) to ACT \>19 (controlled asthma) at 3 months. ACT is a validated five question survey that computes a number indicating asthma control. The instrument range is 1-25, with 25 indication well controlled asthma. A score of less than or equal 19 is considered poorly controlled asthma.
Conditions Studied
Interventions
- BEHAVIORAL PEAKmAAP
- BEHAVIORAL PEAKmAAP-DS
- BEHAVIORAL NutriMap Usual Care
Study Locations (1)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What the registry record for NCT03842033 still lists
NCT03842033 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, below the 7,674-participant average among 9 other Pediatric Asthma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Pediatric Asthma appearing as the primary indexed condition, and to 3 interventions - of which PEAKmAAP is the first listed.
NCT03842033 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT03842033 about?
NCT03842033 is a clinical study titled "Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients". The goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan.
What is the current status of trial NCT03842033?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 370 participants. The study started on 2019-03-04. Estimated completion is 2025-12-30.
What conditions does trial NCT03842033 study?
This clinical trial studies the following conditions: Pediatric Asthma.
What interventions are being tested in trial NCT03842033?
The interventions under investigation include: PEAKmAAP (BEHAVIORAL), PEAKmAAP-DS (BEHAVIORAL), NutriMap Usual Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03842033?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03842033 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03842033's enrollment target sits among peer trials
370 3rd of 9 higher than 7 of 9 other Pediatric Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
The Airports, Air Quality, and Asthma (AAA) Study
RECRUITING · NA
-
Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma
RECRUITING · NA
-
AeviceMD for Pediatric Asthma Management
RECRUITING · NA
-
The Puerto Rico Asthma Integrated Response Program ("PR-AIR")
RECRUITING · NA
-
Social Needs Screening and Chronic Diseases Study (WE CARE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI